A detailed history of Integrity Advisory, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Integrity Advisory, LLC holds 6,720 shares of DXCM stock, worth $537,868. This represents 0.74% of its overall portfolio holdings.

Number of Shares
6,720
Previous 10,977 38.78%
Holding current value
$537,868
Previous $884,000 14.03%
% of portfolio
0.74%
Previous 0.82%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023

SELL
$84.98 - $122.67 $361,759 - $522,206
-4,257 Reduced 38.78%
6,720 $0
Q3 2022

Oct 17, 2022

BUY
$76.35 - $94.18 $48,940 - $60,369
641 Added 6.2%
10,977 $884,000
Q2 2022

Jul 27, 2022

BUY
$67.99 - $132.89 $607,150 - $1.19 Million
8,930 Added 635.14%
10,336 $770,000
Q1 2022

May 05, 2022

BUY
$94.08 - $130.2 $132,276 - $183,061
1,406 New
1,406 $719,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Integrity Advisory, LLC Portfolio

Follow Integrity Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrity Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrity Advisory, LLC with notifications on news.